AstraZeneca opens global strategic R&D center in Kendall Square, Massachusetts
AZN•AstraZeneca opened a global strategic research and development center in Kendall Square, Cambridge, Massachusetts, and said it is investing $1 billion to grow its Massachusetts workforce by more than 50%.
1. New R&D center
AstraZeneca opened a global strategic research and development center in Kendall Square, Cambridge, Massachusetts. The company said it is investing $1 billion to grow its Massachusetts workforce by more than 50%.
